BioNTech SE BNTX
NASDAQ BNTX
$98.45 -0.12 (-0.12%)
As of: Sep 30, 2026 · 3:59 PM EDT

BioNTech SE (BNTX) Current Deferred Revenue (2018 - 2026)

Updated

BioNTech SE (BNTX) posted Current Deferred Revenue of $101.82 million for Q2 2026, down 88.6% from $891.64 million a year earlier and down 0.8% from the prior quarter.

Analysis

BioNTech SE (BNTX) Current Deferred Revenue (2018 - 2026) Analysis & Trends

At the end of FY2025, BioNTech SE's Current Deferred Revenue came in at $102.44 million, down 47.6% from FY2024.

  • Annual Current Deferred Revenue shows a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
  • In prior years, BioNTech SE's Current Deferred Revenue was $195.55 million in FY2024 (-54.4%), $428.76 million in FY2023 (+768.3%), $49.38 million in FY2022 (+379.6%) and $10.3 million in FY2021 (-87.5%).
  • The Q2 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q1 2023.
  • On a year-over-year basis, Current Deferred Revenue has declined in each of the last four quarters, with an average decline of 19.1% over the last eight quarters.
  • The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2023, with growth of 768.3%; the weakest was Q2 2026, with a decline of 88.6%.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $102.67 million (Q1 2026), $102.44 million (Q4 2025) and $256.02 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 BioNTech SE 24.93 Bn -34.44 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 101.82 Mn
Mar 31, 2026 102.67 Mn
Dec 31, 2025 102.44 Mn
Sep 30, 2025 256.02 Mn
Jun 30, 2025 891.64 Mn
Mar 31, 2025 192.39 Mn
Dec 31, 2024 195.55 Mn
Sep 30, 2024 413.92 Mn
Jun 30, 2024 380.79 Mn
Mar 31, 2024 411.95 Mn
Dec 31, 2023 428.76 Mn
Sep 30, 2023 291.74 Mn
Jun 30, 2023 328.96 Mn
Mar 31, 2023 48.94 Mn
Dec 31, 2022 49.38 Mn
Sep 30, 2022 54.25 Mn
Jun 30, 2022 59.65 Mn
Mar 31, 2022 74.52 Mn
Dec 31, 2021 10.30 Mn
Sep 30, 2021 12.38 Mn
API Access

BioNTech SE Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BNTX&period=max&api_key=YOUR_API_KEY